Qualigen Therapeutics Stock (NASDAQ: QLGN) stock price, news, charts, stock research, profile.
Open | $0.290 |
Close | $0.285 |
Volume / Avg. | 53.522K / 72.296K |
Day Range | 0.280 - 0.300 |
52 Wk Range | 0.270 - 1.260 |
Market Cap | $1.886M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 0.79% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Qualigen Therapeutics (NASDAQ: QLGN) through any online brokerage.
Other companies in Qualigen Therapeutics’s space includes: NeuBase Therapeutics (NASDAQ:NBSE), Dermata Therapeutics (NASDAQ:DRMA), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
There is no analysis for Qualigen Therapeutics.
The stock price for Qualigen Therapeutics (NASDAQ: QLGN) is $0.299 last updated May 7, 2024 at 6:16 PM EDT.
There are no upcoming dividends for Qualigen Therapeutics.
Qualigen Therapeutics’s Q4 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Qualigen Therapeutics.
Qualigen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.